Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diastika Biotekindo Tbk. (CHEK) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Diastika Biotekindo Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Diastika Biotekindo Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp132 (market cap 534.73B, 418.3K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Diastika Biotekindo Tbk. is the larger of the two by market cap, and Diastika Biotekindo Tbk. is more actively traded (418.3K versus 41.7K). Which is the better fit depends on your goals.

CHEKDGNS
Market Cap
534.73B316.25B
Volume
418.3K41.7K
Lot
4.18K417
Turnover
54.5M9.66M
Average Price
130.28231.65
Value
54.5M9.66M
Indicative Equilibrium Price
132230
Indicative Equilibrium Volume
202.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CHEK
View details
DGNS
View details

About Diastika Biotekindo Tbk.

PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on CHEK

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS